Goldman Sachs’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Goldman Sachs's PTEN Position: Q2 2026 in Review
Goldman Sachs increased its Patterson-UTI (PTEN) stake by 7.3% in Q2 2026, buying an estimated $12.3M and bringing the position to 16,340,271 shares worth $150M. The position accounts for 0.01% of the portfolio, ranked #933.
Goldman Sachs first reported a position in PTEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $165M in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.
- Goldman Sachs held 16,340,271 shares of Patterson-UTI worth $150M as of Q2 2026.
- Goldman Sachs bought 1,104,737 Patterson-UTI shares in Q2 2026, an estimated $12.3M.
- Patterson-UTI made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #933 holding.
- Goldman Sachs first reported a position in Patterson-UTI in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Patterson-UTI position peaked at $165M in Q1 2026.
- 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.